- Home
- Publications
- Publication Search
- Publication Details
Title
Gut microbiota modulates drug pharmacokinetics
Authors
Keywords
-
Journal
DRUG METABOLISM REVIEWS
Volume -, Issue -, Pages 1-12
Publisher
Informa UK Limited
Online
2018-09-19
DOI
10.1080/03602532.2018.1497647
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Influence of a diet enriched with virgin olive oil or butter on mouse gut microbiota and its correlation to physiological and biochemical parameters related to metabolic syndrome
- (2018) Isabel Prieto et al. PLoS One
- Liver–Microbiome Axis in Health and Disease
- (2018) Timon E. Adolph et al. TRENDS IN IMMUNOLOGY
- Colonization by non-pathogenic bacteria alters mRNA expression of cytochromes P450 in originally germ-free mice
- (2017) L. Jourová et al. FOLIA MICROBIOLOGICA
- Brain–gut–microbiota axis — mood, metabolism and behaviour
- (2017) Timothy G. Dinan et al. Nature Reviews Gastroenterology & Hepatology
- An Atlas of β-Glucuronidases in the Human Intestinal Microbiome
- (2017) Rebecca M. Pollet et al. STRUCTURE
- Reduced metabolic activity of gut microbiota by antibiotics can potentiate the antithrombotic effect of aspirin
- (2016) In Sook Kim et al. BIOCHEMICAL PHARMACOLOGY
- Effects of orally administered antibiotics on the bioavailability of amlodipine
- (2016) Hye Hyun Yoo et al. JOURNAL OF HYPERTENSION
- Role of Intestinal Microbiota in Baicalin-Induced Drug Interaction and Its Pharmacokinetics
- (2016) Keumhan Noh et al. MOLECULES
- The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism
- (2016) Peter Spanogiannopoulos et al. NATURE REVIEWS MICROBIOLOGY
- Tissue-specific actions of FXR in metabolism and cancer
- (2015) Raffaella Maria Gadaleta et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity
- (2015) Bret D. Wallace et al. CHEMISTRY & BIOLOGY
- The small intestine microbiota, nutritional modulation and relevance for health
- (2015) Sahar El Aidy et al. CURRENT OPINION IN BIOTECHNOLOGY
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
- On the Colonic Bacterial Metabolism of Azo-Bonded Prodrugsof 5-Aminosalicylic Acid
- (2014) Tiago Sousa et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Administration of a Probiotic Can Change Drug Pharmacokinetics: Effect of E. coli Nissle 1917 on Amidarone Absorption in Rats
- (2014) Zuzana Matuskova et al. PLoS One
- Eradication of Helicobacter pylori Infection Improves Levodopa Action, Clinical Symptoms and Quality of Life in Patients with Parkinson's Disease
- (2014) Hasriza Hashim et al. PLoS One
- An increase in theAkkermansiaspp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice
- (2013) Na-Ri Shin et al. GUT
- Calcium-Channel Blocker–Clarithromycin Drug Interactions and Acute Kidney Injury
- (2013) Sonja Gandhi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Diet rapidly and reproducibly alters the human gut microbiome
- (2013) Lawrence A. David et al. NATURE
- Predicting and Manipulating Cardiac Drug Inactivation by the Human Gut Bacterium Eggerthella lenta
- (2013) H. J. Haiser et al. SCIENCE
- Bacterial β-glucuronidase inhibition protects mice against enteropathy induced by indomethacin, ketoprofen or diclofenac: mode of action and pharmacokinetics
- (2013) Kyle S. Saitta et al. XENOBIOTICA
- Functional interactions between the gut microbiota and host metabolism
- (2012) Valentina Tremaroli et al. NATURE
- The influence of diet on the gut microbiota
- (2012) Karen P. Scott et al. PHARMACOLOGICAL RESEARCH
- Developing a metagenomic view of xenobiotic metabolism
- (2012) Henry J. Haiser et al. PHARMACOLOGICAL RESEARCH
- Is It Time for a Metagenomic Basis of Therapeutics?
- (2012) H. J. Haiser et al. SCIENCE
- Effects of Intestinal Flora on the Expression of Cytochrome P450 3A in the Liver
- (2012) Makoto Ishii et al. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
- Enteric Microbiome Metabolites Correlate with Response to Simvastatin Treatment
- (2011) Rima Kaddurah-Daouk et al. PLoS One
- Colonization-Induced Host-Gut Microbial Metabolic Interaction
- (2011) S. P. Claus et al. mBio
- Drug metabolome of the Simvastatin formed by human intestinal microbiota in vitro
- (2010) Anna-Marja Aura et al. Molecular BioSystems
- Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa
- (2010) C. De Filippo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme
- (2010) B. D. Wallace et al. SCIENCE
- Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism
- (2009) T. A. Clayton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The gastrointestinal microbiota as a site for the biotransformation of drugs
- (2008) Tiago Sousa et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Helicobacter pyloriinfection and motor fluctuations in patients with Parkinson's disease
- (2008) Won Yong Lee et al. MOVEMENT DISORDERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started